Explorer les evidences

35,5 %The proportion of children aged 6–59 months in Nigeria with malaria fever positive as assessed by rapid diagnostic tests was 35.5%.

Nigeriapaludismeobservé 2018publié 2021International journal of environmental research and public healthPubMeddocument de 6 observations

3,41 aORBeing a survivor of non-intimate partner sexual violence was significantly associated with three times higher odds of vaccine hesitancy (adjusted odds ratio 3.41).

Nigeriagender-based violenceobservé 2021publié 2022African journal of AIDS research : AJARPubMeddocument de 8 observations

29,5 %29.5% of the respondents had good knowledge of breast and cervical cancers and screening.

Nigeriabreast and cervical cancersobservé 2018publié 2023PloS onePubMeddocument de 14 observations

34,4 %34.4% of tuberculosis patients were assigned incorrect treatment outcomes by healthcare workers in Lagos private DOTS facilities.

Nigeriatuberculoseobservé 2016publié 2022Frontiers in public healthPubMeddocument de 11 observations

15,5 %A weighted HIV prevalence of 15.5% was found among female sex workers in Nigeria.

NigeriaVIH/sidaobservé 2020publié 2025Sexually transmitted infectionsPubMeddocument de 12 observations

98,2 %The test efficiency of SickleSCAN™ for sickle cell disease (Hb SS and Hb SC) was 98.2%.

Nigeriadrépanocytosepublié 2017Hemoglobineurope_pmcdocument de 5 observations

16,3 %The prevalence of depression among people living with HIV in two rural secondary health facilities providing antiretroviral therapy services in Southwestern Nigeria was 16.3% between September and December 2020.

Nigeriadépression · VIH/sidaobservé September and December 2020publié 2023AIDS research and therapyPubMeddocument de 8 observations

2 000 NGNThe median maximum amount people living with HIV (PLHIV) on antiretroviral therapy (ART) were willing to pay for premium ART services was NGN2,000 (USD $5.56), with an interquartile range of NGN1,000–NGN3,000.

NigeriaVIH/sidaobservé July and August 2019publié 2023PloS onePubMeddocument de 9 observations

1 250 sexual_contacts1,250 sexual contacts were elicited using the elicitation box model.

NigeriaVIH/sidaobservé Between March 2021 and April 2022publié 2024Global health, science and practicePubMeddocument de 8 observations

28,5 %Generalized obesity was present in 28.5% of participants with kidney dysfunction.

Nigeriakidney dysfunctionpublié 2024West African journal of medicinePubMeddocument de 14 observations

14,2 pointsThe health education intervention yielded a net gain of 14.2 points in knowledge about cervical cancer screening among adult women in Cross River State, Nigeria.

Nigeriacancer du col de l'utéruspublié 2023African journal of reproductive healthPubMeddocument de 4 observations

1,6 yearsThe median participant follow-up was 1.6 years.

Nigeriadrépanocytosepublié 2023BloodPubMeddocument de 8 observations

29 cases29 out of 507 mothers living with HIV were informed about the HPV vaccine.

Nigeriainfection à HPVpublié 2026BMC public healthPubMeddocument de 8 observations

53,9 %The prevalence of any ocular disorder among persons living with HIV/AIDS in Osun State, Nigeria was 53.9%.

NigeriaVIH/sidapublié 2026BMC ophthalmologyPubMeddocument de 9 observations

87,5 %87.5% of female sex workers in Kano State, Nigeria, cited desire to know and confirm HIV status as the primary driver for willingness to use HIV services.

NigeriaVIH/sidaobservé 2023publié 2025PloS onePubMeddocument de 7 observations

60 %Acute demyelinating encephalomyelitis (ADEM) accounted for 60% (n = 6) of the 10 demyelinating disorder cases in the study population.

NigeriaAcute demyelinating encephalomyelitis (ADEM)observé January 2018 to December 2022publié 2024Nigerian journal of clinical practicePubMeddocument de 7 observations

99,7 %Le nitrate de déshydrocorydaline inhibe la croissance de la souche 3D7 de Plasmodium falciparum à 99,7 % avec une concentration inhibitrice 50 (IC50) de 38 nM.

Nigeriapaludisme · souche 3D7observé 2018HAL · Unilimdocument de 173 observations

25 %Recent screening-based studies suggest a β-thalassaemia trait prevalence of up to 25% among individuals without sickle cell disease (SCD) in Africa.

Nigeriadrépanocytose · β-thalassaemiapublié 2026African journal of laboratory medicineeurope_pmcdocument de 5 observations

10 %Clinical pes anserinus tendinitis bursitis syndrome (PATBS) was diagnosed exclusively in 8 female T2DM patients, constituting 10.0% of the total T2DM group.

Nigeriapes anserinus tendinitis bursitis syndrome · type 2 diabetic mellituspublié 2025West African journal of medicinePubMeddocument de 5 observations

3,82 ORSexual minority adolescents with unknown HIV status had significantly higher odds of depressive symptoms (adjusted OR: 3.82; 95% CI: 2.78 to 5.27; p<0.001).

Nigeriadepressive symptomspublié 2022BMJ global healthPubMeddocument de 8 observations

5,7 %Protective efficacy (PE) estimates of PMC with three doses at 80% coverage ranged from 5.7% to 8.8% for clinical malaria in children under two years of age.

Nigeriapaludismepublié 2023Malaria journalPubMeddocument de 6 observations

52,7 %Among 150 seronegative participants, 79 (52.7%) had at least one gastrointestinal parasitic infection.

Nigeriagastrointestinal parasitic infectionspublié 2019Annals of global healthPubMeddocument de 10 observations

30,1 %Sixty-five (30.1%) of 216 inmates were transferred-out without evaluation during TB treatment.

Nigeriatuberculoseobservé 2014–2018publié 2022PloS onePubMeddocument de 11 observations

70,8 %Awareness of cervical cancer was 70.8% among women of a Catholic Parish in Nsukka Local Government Area of Enugu State, Nigeria.

Nigeriacancer du col de l'utéruspublié 2021The Pan African medical journalPubMeddocument de 8 observations

2,13 AORAge less than or equal to 2 years was an independent risk factor for delay in parasite clearance (Adjusted odds ratio = 2.13, 95% confidence interval 1.44–3.15).

Nigeriapaludismeobservé 1996–2008publié 2010Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/1475-2875-9-53